Extension of Bulevirtide monotherapy to 72 weeks in HDV patients with compensated cirrhosis: Efficacy and safety from the italian multicenter study (HEP4Di)

Autor:	M.P. Anolli, E. Degasperi, G. D'Offizi, M.R. Brunetto, G. Verucchi, A. Federico, A. Ciancio, A. Mangia, T.A. Santantonio, N. Coppola, A. Pellicelli, A. Loglio, M. Viganò, F. Pileri, Monia Maracci, M. Puoti, F. Piscaglia, P. Lampertico
Rok vydání:	2023
Předmět:	Hepatology Gastroenterology
Zdroj:	Digestive and Liver Disease. 55:S7
ISSN:	1590-8658
DOI:	10.1016/j.dld.2023.01.012
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::50cd0f47bf4c7072b33d705997f1190c https://doi.org/10.1016/j.dld.2023.01.012 Zobrazit plný text záznamu Full Text from ScienceDirect